Joseph M. Sanzari Children’s Hospital and
K. Hovnanian Children’s Hospital Pediatric Oncology

Offering cutting-edge treatment protocols and hands-on care from newborns to young adults.


Hackensack Meridian Health’s children’s hospitals are leaders in advancing clinical research while providing diagnosis and treatment of all types of cancer, including leukemia, lymphoma, brain tumors, neuroblastoma, bone and kidney tumors as well as rarer tumor types.

Stem Cell Transplantation and Cellular Therapy

Comprehensive Cellular Therapy Program for Malignant and Non-Malignant Diseases Now Incorporating Gene Therapy

New Jersey’s only Pediatric Bone Marrow and Stem Cell Transplant Program at Hackensack Meridian Health Joseph M. Sanzari Children’s Hospital provides patients with access to advanced treatment methods.

Learn More

CAR (Chimeric Antigen Receptor) T-cell Therapy

Hackensack Meridian Health Joseph M. Sanzari Children’s Hospital Offers Novel Therapies to Treat Pediatric Cancer Patients

The Pediatric Stem Cell Transplantation and Cellular Therapy Program offers CAR (Chimeric Antigen Receptor) T-cell therapy for acute lymphoblastic leukemia, among other firsts.

Learn More

Lymphoma

Select Patients with LPHL May Be Spared Chemotherapy

Hackensack Meridian Health Joseph M. Sanzari Children’s Hospital researchers at the forefront of decreasing therapy for children and young adults with a type of Hodgkin lymphoma.

Learn More

Solid Tumors


Several Transdisciplinary and Interinstitutional Efforts Offer Promise

Hackensack Meridian Health Joseph M. Sanzari Children’s Hospital researching better treatments for solid tumors in children.

Learn More

Neuro-Oncology

Several Transdisciplinary and Interinstitutional Efforts Offer Promise

Breakthrough Treatments and Clinical Trials Coming to Pediatric Neuro-Oncology

Learn More

The Cure and Beyond (Survivorship) Program


Hackensack Meridian Health Joseph M. Sanzari Children’s Hospital Offers Oncofertility Consultations

Egg harvesting, sperm banking, ovarian and testicular tissue preservation, and hormonal therapy made possible for pediatric oncology patients.

Learn More